Jyotirmoy Banerjee

12PUBLICATIONS
4CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 27, 2026
ACK family tyrosine kinases as potential therapeutic targets for cancer.

|Sep 05, 2025
The contribution of fibronectin in epileptogenesis: therapeutic potential and mechanistic complexity.

Neha Dixit, Nitin Yadav, Priya

|Jun 14, 2025
Role of vitamin D supplementation and vitamin D receptor in drug-resistant epilepsy: A double-blind placebo-controlled trial conducted in India.

Soumya S Pattnaik, Sudhir C Sarangi, Yajnaseni Dash

|Apr 17, 2024
Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets.

Ozasvi R Shanker, Sonali Kumar, Jyotirmoy Banerjee

|Jan 19, 2024
Cold atmospheric plasma (CAP) treatment increased reactive oxygen and nitrogen species (RONS) levels in tumor samples obtained from patients with low-grade glioma.

Yogesh Aggarwal, Akshay Vaid, Anand Visani

|Nov 26, 2022
Differential Levels of Tryptophan-Kynurenine Pathway Metabolites in the Hippocampus, Anterior Temporal Lobe, and Neocortex in an Animal Model of Temporal Lobe Epilepsy.

Soumil Dey, Vivek Dubey, Aparna Banerjee Dixit

Pageof 2

Frequent Collaborators

7 joint publications

Aparna Banerjee Dixit

1 joint publications

Ramesh Doddamani

1 joint publications

Soumil Dey

1 joint publications

Sudhir C Sarangi